The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.
We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where ...
Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...
Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.
The Register on MSN4d
Google DeepMind CEO says 2025's the year we start popping pills AI helped inventClinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...
Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...
The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...
近日，谷歌创始人之一的德米斯・哈萨比斯（Demis Hassabis）在一次采访中透露，他所创办的公司 Isomorphic Labs 计划在年底前开始一项由人工智能 ...
在达沃斯世界经济论坛上，Google DeepMind的CEO Demis Hassabis震撼发布了一个引人注目的预测：首批由人工智能辅助设计的药物或将在2025年前进行临床试验！作为Isomorphic Labs的负责人，Hassabis表示，"我们预计到年底会有一些AI设计的药物进入临床试验，这是我们的目标。"自2021年以来，Isomorphic ...
值得一提的是，Hassabis与他的同事John ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback